Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.76
-0.03 (-1.08%)
At close: Aug 15, 2025, 3:59 PM
2.77
0.36%
After-hours: Aug 15, 2025, 06:01 PM EDT

Black Diamond Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 70M n/a n/a n/a n/a 4.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a 86K 86K 86K 823K 812K 812K 807K 807K 813K 811K 804K 626K 447K 340K
Gross Profit
n/a 70M n/a -86K -86K -86K 4.81M -823K -812K -812K -807K -807K -813K -811K -804K -626K -447K -340K
Operating Income
-13.42M 54.53M -18.27M -18.13M -22.13M -20.25M -20.86M -24.01M -20.03M -21.56M -21.85M -22.12M -23.17M -25.68M -26.08M -35.36M -34.72M -30.71M
Interest Income
1.12M 595K 565K 516K 464K 637K 324K 439K 539K 622K 677K 562K 386K 406K 588K 776K 948K 1.15M
Pretax Income
-10.56M 56.54M -15.98M -15.56M -19.91M -18.23M -19.41M -23.01M -19.15M -20.88M -18.83M -21.65M -22.93M -25.51M -25.87M -35.08M -34.35M -30.3M
Net Income
-10.56M 56.54M -15.98M -15.56M -19.91M -18.23M -19.41M -23.01M -19.15M -20.19M -17.05M -20.62M -22.3M -24.93M -25.87M -35.08M -34.35M -30.3M
Selling & General & Admin
4.1M 4.96M 5.98M 5.22M 9.57M 6.7M 5.57M 7.86M 6.88M 6.81M 7.24M 6.28M 6.98M 7.89M 6.42M 7.74M 8M 7.89M
Research & Development
9.32M 10.51M 12.3M 12.91M 12.47M 13.46M 15.2M 16.15M 13.15M 14.75M 14.61M 15.85M 16.2M 17.79M 19.66M 27.63M 26.72M 22.82M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 566K 341K 64K 115K -92K -143K -234K -375K -489K -584K -740K
Operating Expenses
13.42M 15.47M 18.27M 18.13M 22.04M 20.16M 20.77M 24.01M 20.03M 21.56M 21.85M 22.12M 23.17M 25.68M 26.08M 35.36M 34.72M 30.71M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 15.47M 18.27M 18.13M 22.13M 20.25M 20.86M 24.01M 20.03M 21.56M 21.85M 22.12M 23.17M 25.68M 26.08M 35.36M 34.72M 30.71M
Income Tax Expense
n/a n/a n/a n/a n/a 42.72K n/a -115K n/a -686K -1.78M -1.03M -629K -578K n/a n/a n/a n/a
Shares Outstanding (Basic)
56.8M 56.66M 56.61M 56.51M 55.16M 51.81M 51.64M 50.94M 36.52M 36.48M 36.39M 36.35M 36.29M 36.27M 36.23M 36.22M 36.18M 36.12M
Shares Outstanding (Diluted)
56.8M 57.67M 56.61M 56.51M 55.16M 51.81M 51.64M 50.94M 36.52M 36.48M 36.39M 36.35M 36.29M 36.27M 36.23M 36.22M 36.18M 36.12M
EPS (Basic)
-0.19 1.00 -0.28 -0.28 -0.36 -0.35 -0.38 -0.45 -0.52 -0.55 -0.47 -0.57 -0.61 -0.69 -0.71 -0.97 -0.95 -0.84
EPS (Diluted)
-0.19 0.98 -0.28 -0.28 -0.36 -0.35 -0.38 -0.45 -0.52 -0.55 -0.47 -0.57 -0.61 -0.69 -0.71 -0.97 -0.95 -0.84
EBITDA
-13.42M 54.62M -18.19M -18.04M -22.04M -20.16M -20.77M -24.01M -19.92M -21.44M -21.73M -22M -23.05M -25.55M -25.74M -35.32M -34.72M -30.69M
EBIT
n/a 54.53M -18.27M -18.13M -22.13M -20.25M -20.86M -24.01M -20.03M -21.56M -21.85M -22.12M -23.17M -25.68M -25.87M -35.36M -34.72M -30.71M
Depreciation & Amortization
n/a 87K 85K 86K 86K 86K 86K 823K 812K 812K 807K 807K 813K 811K 804K 626K 447K 340K